GINKARDIO TABLET (GINKGO FOLIUM TABLET)

Indications

• Antioxidant support
• Anti-inflammatory conditions
• Cardiovascular disease prevention
• Cancer prevention and therapy adjunct
• Metabolic syndrome management

Dosage

Children: Refer to established guidelines for specific dosing information, as doses may vary based on formulation and intended use.

Adults: Refer to established guidelines for specific dosing information, as doses may vary based on formulation and intended use.

Mechanism of action

Favonol exhibits its effects primarily through the modulation of signaling pathways related to oxidative stress and inflammation. It can scavenge free radicals, thereby reducing oxidative damage to cells. Additionally, favonol may enhance the activity of antioxidant enzymes and inhibit pro-inflammatory cytokines, contributing to its anti-inflammatory effects.

Pharmacodynamics

The pharmacodynamic properties of favonol include its role in reducing oxidative stress and inflammation. It is known to influence various cell signaling pathways, such as the NF-kB pathway, which is important in regulating immune response and inflammation. Favonol's ability to modulate these pathways makes it a potential agent for preventing or treating conditions related to oxidative stress.

Pharmacokinetics

Favonol is generally well-absorbed in the gastrointestinal tract after ingestion, but its bioavailability can be affected by factors such as food matrix and formulation. It undergoes extensive metabolism in the liver, primarily through phase II reactions like glucuronidation and sulfation. The elimination half-life varies but is typically short, necessitating repeated dosing for sustained effects. Excretion occurs mainly via urine, with metabolites being the primary forms detected.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Limited data; use with caution and only if the benefits outweigh the risks.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Heart failure
• Atrial fibrillation
• Atrial flutter

Dosage

Children: Refer to BNF for Children for specific dosing recommendations based on the indication and patient factors.

Adults: Refer to BNF for specific dosing recommendations based on the indication and patient factors.

Mechanism of action

Glycosides exert their pharmacological effects primarily by inhibiting the Na+/K+ ATPase enzyme in cardiac myocytes. This inhibition leads to an increase in intracellular sodium concentration, which subsequently causes an increase in intracellular calcium via the sodium-calcium exchanger. The increased calcium concentration enhances myocardial contractility (positive inotropic effect), improves cardiac output, and reduces heart rate through vagal stimulation.

Pharmacodynamics

Glycosides enhance the force of myocardial contraction, improve the efficiency of the heart, and can lead to reduced symptoms of heart failure. They also exhibit a narrow therapeutic index, meaning the difference between therapeutic and toxic doses is small. Toxicity may manifest as arrhythmias, gastrointestinal disturbances, and neurological symptoms.

Pharmacokinetics

Glycosides are well absorbed from the gastrointestinal tract, with bioavailability varying based on the specific compound and its formulation. They are primarily eliminated through renal excretion and undergo hepatic metabolism. The half-life of glycosides can vary significantly; for example, digoxin has a half-life of approximately 36 hours in patients with normal renal function. Dosing adjustments may be necessary in cases of renal impairment.

Contra-indications

• Hypersensitivity to glycosides or any of the excipients
• Severe bradycardia
• Heart block (unless a pacemaker is in place)
• Hypertrophic obstructive cardiomyopathy
• Ventricular fibrillation

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Loss of appetite
• Visual disturbances (e.g., yellow-green vision)
• Arrhythmias
• Palpitations
• Fatigue
• Confusion

Interactions

• Diuretics (increased risk of hypokalemia)
• Calcium salts (risk of arrhythmias)
• Beta-blockers (enhanced bradycardic effect)
• Antibiotics (e.g., erythromycin, clarithromycin; increased risk of toxicity)
• Antidepressants (e.g., tricyclics; increased risk of toxicity)

Precautions

• Monitor renal function regularly, as glycosides are renally excreted
• Use caution in patients with electrolyte imbalances, particularly hypokalemia or hypercalcemia
• Careful monitoring in geriatric patients or those with hepatic impairment
• Consider dose adjustments in patients with atrial fibrillation

Pregnancy

Glycosides should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited human studies are available.

Breast-feeding

Glycosides are excreted in breast milk, and caution is advised when administering to nursing mothers due to potential adverse effects on the infant.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Oral tablets
• Oral solution
• Injectable forms

Indications

• Bacterial infections
• Fungal infections
• Cancer treatment
• Anti-inflammatory therapies

Dosage

Children: Refer to specific lactone formulations for pediatric dosing instructions, as they may differ based on the age and weight of the child.

Adults: Refer to specific lactone formulations for dosing instructions, as they can vary widely depending on the indication and specific drug.

Mechanism of action

Lactones exert their effects through various mechanisms, including the inhibition of protein synthesis, modulation of cell signaling pathways, and disruption of cellular metabolism. Some lactones can interfere with the activity of specific enzymes, such as those involved in fatty acid metabolism, while others may disrupt the integrity of cellular membranes.

Pharmacodynamics

The pharmacodynamics of lactones depend on their specific structure and the biological target they interact with. Generally, lactones can induce apoptosis in cancer cells, inhibit bacterial cell wall synthesis, or modulate immune responses. Their efficacy is often related to their ability to penetrate cell membranes and reach intracellular targets.

Pharmacokinetics

Lactones are typically absorbed well from the gastrointestinal tract when administered orally. They may undergo extensive first-pass metabolism in the liver, which can affect their bioavailability. The distribution of lactones in the body varies, but they tend to have high protein binding. Elimination is primarily through hepatic metabolism, with renal excretion of metabolites. The half-life of lactones can vary significantly based on their chemical structure.

Pregnancy

Lactones should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult relevant guidelines and literature for specific lactones.

Breast-feeding

Lactones may be excreted in breast milk; caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct light. Specific storage conditions may vary depending on the specific lactone compound.

Indications

• Aromatherapy
• Anti-inflammatory treatment
• Pain relief
• Antimicrobial therapy
• Anxiety and stress relief

Dosage

Children: Refer to specific terpene product guidelines or consult a healthcare professional. Dosing will vary based on the terpene type and intended use.

Adults: Refer to specific terpene product guidelines or consult a healthcare professional. Dosing will vary based on the terpene type and intended use.

Mechanism of action

Terpenes exert their effects through various mechanisms, including modulation of neurotransmitter systems, antioxidant activity, and interaction with receptors such as cannabinoid receptors. They can influence cellular signaling pathways, leading to altered physiological responses.

Pharmacodynamics

The pharmacodynamics of terpenes can vary widely depending on the specific type of terpene and its concentration. Generally, terpenes can affect mood, pain perception, and inflammation. Their synergistic effects with other compounds, particularly cannabinoids in cannabis, may enhance therapeutic outcomes.

Pharmacokinetics

Terpenes are lipophilic and can be absorbed well through the skin and mucous membranes. They are metabolized primarily in the liver, undergoing phase I and phase II metabolism. The elimination half-life of terpenes can vary greatly depending on their structure and the route of administration.

Pregnancy

There is limited information on the safety of terpenes during pregnancy. Consult healthcare professionals for specific advice.

Breast-feeding

Caution is advised when using terpenes while breastfeeding due to limited data on safety.

Storage

Store at room temperature, away from direct light and moisture.

Dosage

Children: Paediatric dosing should also be determined based on the specific formulation and clinical context. Refer to appropriate paediatric guidelines.

Adults: Dosage would depend on the specific formulation and clinical scenario. Refer to established guidelines for specific dosing.

Mechanism of action

The mechanism of action would depend on the specific formulation or active ingredients referred to as 'total'. For example, in the context of total parenteral nutrition, it provides essential nutrients (carbohydrates, proteins, fats, vitamins, and minerals) directly into the bloodstream, bypassing the gastrointestinal tract.

Pharmacodynamics

Pharmacodynamics would vary widely based on the specific active ingredients within the formulation. In the case of total parenteral nutrition, its pharmacodynamics involve the absorption of macronutrients and micronutrients into the body for metabolic processes.

Pharmacokinetics

Pharmacokinetics would also vary based on the specific components. For example, when discussing total parenteral nutrition, the components are absorbed into the bloodstream, metabolized by the liver, and utilized by various tissues in the body. The elimination of waste products occurs primarily through the kidneys.